Epigenetic-based combination therapy and liposomal codelivery overcomes osimertinib-resistant NSCLC via repolarizing tumor-associated macrophages
Article in Acta Pharmacologica Sinica (December 2023)
The most recent citing publications are shown below. View all 5 publications that cite this research output on Dimensions.
Article in Acta Pharmacologica Sinica (December 2023)
Article in Cancer Medicine (March 2023)
Article in Blood Reviews (March 2023)